Wegovy sales 2023?

How much Wegovy did Novo Nordisk sell in 2023?

Wegovy (semaglutide) sales for 2023 are reported as part of Novo Nordisk’s overall financial disclosures. The company breaks out Wegovy sales within its obesity/diabetes business reporting rather than always publishing a single standalone “Wegovy 2023 sales” figure in marketing terms.

Where to find the exact 2023 Wegovy sales number (Novo Nordisk reporting)

To get the precise 2023 figure you’re looking for, use Novo Nordisk’s official annual reporting materials for 2023 (annual report and/or full-year results presentation). Those documents include the company’s stated revenue for Wegovy and its other key products.

Are there different “sales” figures people mean for Wegovy?

Searchers often mean one of these:
- Revenue reported for Wegovy in Novo Nordisk financial statements.
- Prescription/market access volume (doses sold) rather than revenue.
- Regional sales (e.g., US vs. Europe) that may appear in additional tables.

If you tell me whether you want “revenue ($)” or “units/doses,” and whether you want global or a specific country/region, I can narrow it to the right reported metric.